Professionals 93 results
Capabilities 28 results
Industry
Industry
Practice Area
Experience 3 results
Experience
|December 20, 2021
ACON Investments' Acquisition of Vitalis Group
Experience
|July 17, 2020
Defended Generic Drug Manufacturer in Trade Dress Infringement Case
Experience
|March 29, 2019
Rare Noninfringement Jury Verdict for Teva N.A. in Patent Infringement Case for Suboxone® Tablets
Insights & News 333 results
Client Alert
|July 10, 2024
|3 Min Read
June 2024 Presidential Debate: Key Policy Takeaways
Benefits Blast
|July 9, 2024
|3 Min Read
Notable Decisions of the 2024 U.S. Supreme Court Term Impacting Group Health Plans
As the Supreme Court’s 2024 term comes to a close, we want to highlight several decisions that impact employer-sponsored group health plans. Health plan sponsors will want to monitor the impact of these decisions.
Product Liability & Mass Torts Digest
|July 2, 2024
|6 Min Read
The California Supreme Court has recognized a new path for plaintiffs to prove causation in failure-to-warn cases against manufacturers of prescription drugs and medical devices. Under the learned intermediary doctrine, such manufacturers have a duty to warn physicians of the risks associated with their products but do not have a duty to warn patients.
Other Results 32 results
Law Glossary
Law Glossary
What Is the Approval Process for Generic Drugs?
Law Glossary
What Is the Standard for the FDA to Grant a Generic Drug License?